National Pharma Audioconference: The Implications of the New Medicare Prescription Drug Legislation for Pharmaceutical Manufacturers, PBMs and Health Plans
Wednesday, January 14, 2004
1:00 pm - 2:30 pm (Eastern)
12:00 pm - 1:30 pm (Central)
11:00 am - 12:30 pm (Mountain)
10:00 am - 11:30 am (Pacific)
|
For future information about The National Congress on the Future of Genomics, Biotechnology and Pharmaceuticals Conference Series, please complete the form below.
|
|
Featured Faculty
|
|
G. Lawrence Atkins, Ph.D.
Senior Director, Public Policy and Reimbursement
Schering-Plough Corporation
Washington, DC
Anthony A. Barrueta, Esq.
Senior Counsel, Government Relations
Kaiser Foundation Health Plan, Inc.
Oakland, CA
Terry Latanich
Government Affairs Consultant, MedcoHealth
Former Chair, Government Healthcare Programs Committee
Pharmaceutical Care Management Association
Washington, DC
Ian Spatz
Vice President, Public Policy
Merck & Co., Inc.
Washington, DC
John Iglehart
Founding Editor, Health Affairs
Washington, DC
(Moderator)
|
|
SAVE THE FOLLOWING DATES!
|
National Pharma Audioconference: PBM Regulation, Investigation, Prosecution and Compliance
Featuring: James Sheehan, Esq., Assistant U.S. Attorney, Chief, Civil Division, Eastern District of Pennsylvania
Tuesday, February 10, 2004
1:00 pm - 2:30 pm (Eastern)
|
National Medicare Prescription Drug Congress
February 25 - 27, 2004
Washington, DC
Click here for more info
|
|
